Fecal transplant for type 2 diabetes and hashimoto's
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help improve blood sugar and thyroid antibody levels in people with type 2 diabetes and Hashimoto's thyroiditis. If you qualify, you might get a chance to try this new approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with type 2 diabetes.
- You have tested positive for thyroid antibodies (TPOAb and TgAb) and have thyroid changes seen on ultrasound.
- Your diabetes and thyroid medications have been the same for at least 3 months.
- You have not taken antibiotics, probiotics, or prebiotics in the last 4 weeks.
- You do not have serious gut problems, weak immune system, recent severe infections, other autoimmune diseases, cancer, or severe organ failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether transferring healthy stool bacteria into your gut (called fecal microbiota transplantation) can help improve blood sugar control and heart health in people with type 2 diabetes and heart disease. It is a small, early-stage study to see if the treatment is safe and well-tolerated.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study tests a combination of a fecal microbiota transplant (FMT), a calorie-restricted diet, and a type 2 diabetes medication (semaglutide) for people with obesity and recently diagnosed type 2 diabetes. The goal is to see if this approach can improve blood sugar control and weight loss.
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
This Phase 2 study tests whether a fecal microbiota transplant (a processed transplant of gut bacteria) after an allogeneic bone marrow transplant is safe and helpful. Participants may benefit by improving recovery in the gut microbiome during the post-transplant period.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
Hear when a new Autoimmune Thyroid Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.